ストックスクリーナーアプリを入手
9.50
1.45%
-0.14
アフターアワーズ：
9.48
-0.02
-0.21%
前日終値:
$9.64
開ける：
$9.65
24時間の取引高:
575.73K
Relative Volume:
0.61
時価総額：
$859.18M
収益：
$54.55M
当期純損益:
$-193.57M
株価収益率:
-3.2872
EPS:
-2.89
ネットキャッシュフロー:
$-181.86M
1週間 パフォーマンス:
-15.71%
1か月 パフォーマンス:
-1.04%
6か月 パフォーマンス:
-65.25%
1年 パフォーマンス:
-31.90%
1日の値動き範囲:
$9.50
$10.03
1週間の範囲:
$9.02
$11.17
52週間の値動き範囲:
$8.18
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
名前
Nurix Therapeutics Inc
セクター
電話
(415) 660-5320
住所
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
NRIX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
9.50 | 859.18M | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-17 | 開始されました | Leerink Partners | Market Perform |
| 2024-12-10 | 開始されました | BTIG Research | Buy |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-10-11 | 開始されました | Jefferies | Buy |
| 2024-09-06 | 再開されました | Robert W. Baird | Outperform |
| 2024-07-31 | 開始されました | Truist | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2023-03-09 | 開始されました | Barclays | Overweight |
| 2023-02-28 | 開始されました | Oppenheimer | Outperform |
| 2022-10-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-31 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 開始されました | Wells Fargo | Equal Weight |
| 2021-12-29 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-14 | 開始されました | SVB Leerink | Outperform |
| 2021-06-04 | 再開されました | Robert W. Baird | Outperform |
| 2021-04-30 | 再開されました | Piper Sandler | Overweight |
| 2021-04-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-04-14 | 開始されました | Berenberg | Buy |
| 2020-11-19 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-18 | 開始されました | JP Morgan | Overweight |
| 2020-08-18 | 開始されました | Needham | Buy |
| 2020-08-18 | 開始されました | Piper Sandler | Overweight |
| 2020-08-18 | 開始されました | Stifel | Buy |
すべてを表示
Nurix Therapeutics Inc (NRIX) 最新ニュース
135,903 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Purchased by First Trust Advisors LP - MarketBeat
Raymond James Financial Inc. Takes $1.03 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Deep Track Capital LP Reduces Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Voya Investment Management LLC Buys 34,811 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Invesco Ltd. Decreases Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Schonfeld Strategic Advisors LLC Boosts Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by JPMorgan Chase & Co. - MarketBeat
RA Capital Management L.P. Acquires Shares of 1,333,333 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Price T Rowe Associates Inc. MD - MarketBeat
Needham & Company LLC Reaffirms "Buy" Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat
Darwin Global Management Ltd. Invests $3.08 Million in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Boxer Capital Management LLC Makes New Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Lord Abbett & CO. LLC Boosts Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
(NRIX) Trading Signals - news.stocktradersdaily.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by T. Rowe Price Investment Management Inc. - MarketBeat
Nurix therapeutics’ chief scientific officer sells $38,841 in stock By Investing.com - Investing.com South Africa
Nurix therapeutics’ chief scientific officer sells $38,841 in stock - Investing.com
Nurix Therapeutics Executives Sell Shares for Tax Obligations - TradingView
Breaking Down Nurix Therapeutics: 7 Analysts Share Their Views - Benzinga
Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs - The Manila Times
Russell Investments Group Ltd. Grows Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Unveils First-in-Class AI Platform to Unlock Undruggable Proteins | NRIX Stock News - Stock Titan
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Up 6.4%Here's Why - MarketBeat
Nurix Therapeutics reports breakthroughs in cancer drug research - Investing.com Australia
Jump Financial LLC Purchases New Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics Presents Positive Preclinical Data at the AAC - GuruFocus
Nurix Therapeutics Showcases Promising Preclinical Data for BTK, BRAF, and Aurora A Kinase Degraders at AACR 2025 Annual Meeting - Nasdaq
Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets - The Manila Times
Revolutionary Brain-Penetrant Cancer Drugs Outperform Competitors: 10,000 Proteins Destroyed Per Hour - Stock Titan
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $30.44 Average Price Target from Analysts - MarketBeat
Geode Capital Management LLC Acquires 137,087 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Wasatch Advisors LP - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Shares Gap DownWhat's Next? - MarketBeat
Affinity Asset Advisors LLC Raises Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics Inc (NRIX) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):